Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study

被引:10
|
作者
Guleria, Sonia [1 ]
Jensen, Allan [1 ]
Kjaer, Susanne K. [1 ,2 ]
机构
[1] Danish Canc Soc, Res Ctr, Unit Virus Lifestyle & Genes, Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Dept Gynecol, Copenhagen, Denmark
关键词
Benign ovarian tumors; Borderline ovarian tumors; Ovarian cancer; Cohort study; Denmark; FOLLOW-UP; CANCER; POPULATION; DIAGNOSIS; NEOPLASMS; SURVIVAL;
D O I
10.1016/j.ygyno.2017.11.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. A growing number of studies suggest that some ovarian cancers can arise from benign and borderline ovarian tumors. However, studies on the association between benign and borderline ovarian tumors are lacking. We studied the overall-and histotype-specific risk of borderline ovarian tumors among women with a benign ovarian tumor. Methods. This nationwide cohort study included all Danish women diagnosed with a benign ovarian tumor (n = 139,466) during 1978-2012. The cohort was linked to the Danish Pathology Data Bank and standardized incidence ratios (SIR) with 95% confidence intervals (CI) were calculated. Results. Women with benign ovarian tumors had increased risks for subsequent borderline ovarian tumors (SIR 1.62, 95% CI 1.43-1.82), and this applied to both serous (SIR 1.69, 95% CI 1.39-2.03) and mucinous (SIR 1.75, 95% CI 1.45-2.10) histotypes of borderline ovarian tumors. The risk for borderline ovarian tumors was primarily increased for women diagnosed with a benign ovarian tumor before 40 years of age. The risk remained increased up to 9 years after a benign ovarian tumor diagnosis. Finally, the associations did not change markedly when analyzed for the different histotypes of benign (solid and cystic tumors) and borderline (serous and mucinous tumors) ovarian tumors. Conclusions. Women with benign ovarian tumors have a long-term increased risk for borderline ovarian tumors. However, as all associations in this study were only adjusted for age and calendar period of diagnosis, more studies that are able to adjust for additional potential confounding variables are required to further understand these associations. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 50 条
  • [41] MANAGEMENT OF BORDERLINE OVARIAN TUMORS
    Tirnovanu, Mihaela-Camelia
    Amancei, Simona
    Dumitrescu, A.
    Onofriescu, M.
    Dumitrascu, Irina
    [J]. MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2012, 116 (04): : 1069 - 1075
  • [42] Borderline ovarian tumors - Reply
    Seidman, JD
    Kurman, RJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (07) : 905 - 907
  • [43] Borderline ovarian tumors and fertility
    Nam, Joo-Hyun
    [J]. CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2010, 22 (03) : 227 - 234
  • [44] Borderline ovarian tumors:: An update
    Tulpin, L.
    Rouzier, R.
    Morel, O.
    Malartic, C.
    Darai, E.
    Barranger, E.
    [J]. GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2008, 36 (04): : 422 - 429
  • [45] Management of borderline ovarian tumors
    du Bois, A.
    Trillsch, F.
    Mahner, S.
    Heitz, F.
    Harter, P.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 20 - 22
  • [46] Treatment for fertility and risk of ovarian tumors of borderline malignancy
    Parazzini, F
    Negri, E
    La Vecchia, C
    Moroni, S
    Polatti, A
    Chiaffarino, F
    Surace, M
    Ricci, E
    [J]. GYNECOLOGIC ONCOLOGY, 1998, 68 (03) : 226 - 228
  • [47] Risk of Recurrence and Management of Borderline Ovarian Tumors.
    Black, Jonathan D.
    Rutherford, Thomas J.
    Ratner, Elena
    Yoo, Naomi
    Azodi, Masoud
    Buza, Natalia
    Tavassoli, Fattaneh
    Schwartz, Peter E.
    [J]. REPRODUCTIVE SCIENCES, 2013, 20 (S3) : 312A - 312A
  • [48] Ovulation induction treatment and risk of borderline ovarian tumors
    Cusido, Maite
    Fabregas, Rafael
    Barris, Pere S.
    Escayola, Cecilia
    Barri, Pere Nolsac
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2007, 23 (07) : 373 - 376
  • [49] Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study
    Helpman, Limor
    Yaniv, Assaf
    Beiner, Mario E.
    Aviel-Ronen, Sarit
    Perri, Tamar
    Ben-Baruch, Gilad
    Ben-David, Liat Hogen
    Jakobson-Setton, Ariella
    Korach, Jacob
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2017, 96 (11) : 1300 - 1306
  • [50] Ovarian stimulation and borderline ovarian tumors: a case-control study
    Mosgaard, BJ
    Lidegaard, O
    Kjaer, SK
    Schou, G
    Andersen, AN
    [J]. FERTILITY AND STERILITY, 1998, 70 (06) : 1049 - 1055